APA (7th ed.) Citation

Amber Loren O. King, B., Fatima N. Mirza, M., Julia M. Lewis, P., Kacie R. Carlson, P., Scott Huntington, M., Francine M. Foss, M., & Michael Girardi, M. (2021). B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma. Elsevier.

Chicago Style (17th ed.) Citation

Amber Loren O. King, BA, MPH Fatima N. Mirza, PhD Julia M. Lewis, PA Kacie R. Carlson, MD Scott Huntington, MD Francine M. Foss, and MD Michael Girardi. B-cell Lymphoma 2 Inhibitor Venetoclax Treatment of a Patient with Cutaneous T-cell Lymphoma. Elsevier, 2021.

MLA (9th ed.) Citation

Amber Loren O. King, BA, et al. B-cell Lymphoma 2 Inhibitor Venetoclax Treatment of a Patient with Cutaneous T-cell Lymphoma. Elsevier, 2021.